Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Mitchell
News Release
Mitchell Congratulates 2018 mPower Award Winners
Celebrating customers for delivering an excellent customer experience through business innovations
Workers' Comp
Article
StateWatch: Bill Review October 2018
Keep current with new legislation and its potential effect on your organization.
Mitchell
Conference
The SEMA Show 2018
The SEMA Show is the premier automotive specialty products trade event in the
Mitchell
Article
2019 CMS Medicare Payments: Proposed Changes and What They Mean for P&C Insurers
Several states in auto and workers’ compensation claims administration have adopted the Centers of Medicare and Medicaid Services’ (CMS) fee schedu
Workers' Comp
News Release
Genex Services Extends Care Continuum Through PCS Acquisition
Specialty network provider helps Genex expand and streamline its medical management services
Workers' Comp
News Release
Mitchell and Genex sign merger agreement that brings together leaders in medical compliance, cost containment and clinical solutions
Genex to become a new division, continuing to deliver industry leading clinical solutions